AM

Ashit Manek

Active Director Director DIN 11195533
DIN 11195533 First appointment Jul 2025 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Jul 2025
Shareholding value Locked Premium profile

About Ashit Manek

Ashit Manek has 1 years in corporate governance. Holds Director role. Currently with 1 company, including Prolove Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 11195533
Primary Designation Director
First Appointment 19 Jul 2025
Oldest Company Age 5 yrs

Current companies

Company Designation Appointment Founded Status
Prolove Pharma Private Limited U24296GJ2021PTC124109
Director 19 Jul 2025 2021 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Prolove Pharma Private Limited
Premium access

Shareholding and investment profile for Ashit Manek

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ashit Manek

Ashit Manek has 1 years in corporate governance. Holds Director role. Currently with 1 company, including Prolove Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Ashit Manek is associated with 1 company as Director.

Ashit Manek has expertise in General Business.

Ashit Manek has 1 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available